Probity Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Probity Advisors's AMGN Position: Q2 2021 in Review
Probity Advisors sold out of Amgen (AMGN) in Q2 2021, closing a stake of 839 shares — an estimated $209K sold.
Probity Advisors first reported a position in AMGN in Q1 2017 and held it in 16 quarters. The position peaked at $313K in Q3 2018. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.
- Probity Advisors reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
- Probity Advisors sold 839 Amgen shares in Q2 2021, an estimated $209K.
- Probity Advisors first reported a position in Amgen in Q1 2017 and held it in 16 quarters.
- Probity Advisors's Amgen position peaked at $313K in Q3 2018.
- 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.
Based on Probity Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.